61
Researchers at Spain’s National Cancer Research Center have found that a triple combination therapy eliminated pancreatic tumors in mice and prevented recurrence, marking a major scientific breakthrough against one of the deadliest cancers.
The study, published in December 2025 in the scientific journal PNAS, revealed that targeting three key points in the KRAS oncogene pathway led to lasting tumor regression in preclinical trials.
TheDiggerNews.com recalls that breakthroughs like this show how medical progress grows from humanity’s long struggle against disease.
Throughout history, illness has fueled both fear and innovation, prompting scientists to develop new tools and life-saving treatments to address the challenges of their time.
